Tenet Healthcare (NYSE: THC) Earnings Q3 2010

View Tenet Healthcare's (NYSE: THC) Q3 Earnings Report


  • Net income  of $932 million compared to $3 million net loss in Q3 2009
  • Earnings of $1.68 per diluted share compared to a loss of $0.01 per diluted share in Q3 2009
  • Deferred tax benefit of $981 million recognized, $1.75 per diluted share
  • Early extinguishment of debt loss of $55 million, or $0.06 per diluted share
  • Outlook for 2010 net income from continuing operations increased to $110 million-$140 million
  • In October, $46 million in medical office building sales proceeds received
  • California provider fee plan receives partial CMS approval in October
  • $64 million in net revenue expected for Q4
  • $800 million new bank credit line completed

Check out Tenet Healthcare's current earnings estimates from CNN Money

See how THC is performing right now

Tenet's website: www.tenethealth.com

Suggested Articles

John Muir Health is joining forces with Optum as part of an effort to maintain its independence, the two companies announced. 

Clinical Pathology Laboratories, based in Austin, Texas, says 2.2 million patients may have had their personal information compromised.

A global budget model launched by Blue Cross Blue Shield of Massachusetts slowed healthcare spending growth by 12% over eight years.